3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
23
Sarcoma
9
Dermatologic
3
Thoracic
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Gastrointestinal
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Genitourinary
1
Endocrine
1
Breast
1
Conditions
Breast Neoplasms
111
Triple Negative Breast Neoplasms
25
Lung Neoplasms
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Laryngeal Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Bile Duct Neoplasms
2
Interventions
pembrolizumab
3
fludarabine
2
Paclitaxel
2
Gemcitabine
2
Cyclophosphamide
2
Azacitidine
2
vocimagene amiretrorepvec
1
temsirolimus
1
spartalizumab
1
sonidegib
1
sacituzumab govitecan
1
ruxolitinib
1
rucaparib
1
ridaforolimus
1
pazopanib
1
motexafin gadolinium
1
lenvatinib
1
durvalumab
1
depatuxizumab mafodotin
1
cediranib
1
cc-486
1
carboxyamido-triazole
1
abiraterone
1
Thalidomide
1
Temozolomide
1
Sorafenib
1
Sirolimus
1
Radiation
1
Quality of Life
1
Proton Pump Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Drug Therapy
×
Breast
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled